{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:14:04Z","timestamp":1790255644528,"version":"4.1.0"},"reference-count":62,"publisher":"Impact Journals, LLC","issue":"51","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,12,20]]},"DOI":"10.18632\/oncotarget.13063","type":"journal-article","created":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T06:08:20Z","timestamp":1478239700000},"page":"85641-85649","source":"Crossref","is-referenced-by-count":30,"title":["Role of DNA repair machinery and p53 in the testicular germ cell cancer: a review"],"prefix":"10.18632","volume":"7","author":[{"given":"Francesco Jacopo","family":"Romano","sequence":"first","affiliation":[{"name":"Progetto ONCONET2.0, Linea Progettuale 14 per L'implementazione della Prevenzione e Diagnosi Precoce del Tumore alla Prostata e Testicolo, Regione Campania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Rossetti","sequence":"additional","affiliation":[{"name":"Progetto ONCONET2.0, Linea Progettuale 14 per L'implementazione della Prevenzione e Diagnosi Precoce del Tumore alla Prostata e Testicolo, Regione Campania, Italy"},{"name":"Division of Medical Oncology, Department of Uro-Gynaecological Oncology, Istituto Nazionale Tumori \u2018Fondazione G. Pascale', IRCCS, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenza","family":"Conteduca","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS, Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Schepisi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS, Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Cavaliere","sequence":"additional","affiliation":[{"name":"Progetto ONCONET2.0, Linea Progettuale 14 per L'implementazione della Prevenzione e Diagnosi Precoce del Tumore alla Prostata e Testicolo, Regione Campania, Italy"},{"name":"Department of Onco-Ematology Medical Oncology, S.G. Moscati Hospital of Taranto, Taranto, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella Di","family":"Franco","sequence":"additional","affiliation":[{"name":"Progetto ONCONET2.0, Linea Progettuale 14 per L'implementazione della Prevenzione e Diagnosi Precoce del Tumore alla Prostata e Testicolo, Regione Campania, Italy"},{"name":"Radiation Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori \u2018Fondazione Giovanni Pascale', IRCCS, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira La","family":"Mantia","sequence":"additional","affiliation":[{"name":"Progetto ONCONET2.0, Linea Progettuale 14 per L'implementazione della Prevenzione e Diagnosi Precoce del Tumore alla Prostata e Testicolo, Regione Campania, Italy"},{"name":"Pathology Unit, Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d-IRCCS, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Castaldo","sequence":"additional","affiliation":[{"name":"Progetto ONCONET2.0, Linea Progettuale 14 per L'implementazione della Prevenzione e Diagnosi Precoce del Tumore alla Prostata e Testicolo, Regione Campania, Italy"},{"name":"Department of Uro-Gynaecological Oncology, Division of Urology, Istituto Nazionale Tumori \u2018Fondazione G. Pascale', IRCCS, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Nocerino","sequence":"additional","affiliation":[{"name":"Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori \u2018Fondazione Giovanni Pascale', IRCCS, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Ametrano","sequence":"additional","affiliation":[{"name":"Progetto ONCONET2.0, Linea Progettuale 14 per L'implementazione della Prevenzione e Diagnosi Precoce del Tumore alla Prostata e Testicolo, Regione Campania, Italy"},{"name":"Radiation Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori \u2018Fondazione Giovanni Pascale', IRCCS, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Cappuccio","sequence":"additional","affiliation":[{"name":"Progetto ONCONET2.0, Linea Progettuale 14 per L'implementazione della Prevenzione e Diagnosi Precoce del Tumore alla Prostata e Testicolo, Regione Campania, Italy"},{"name":"Psicology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori \u2018Fondazione Giovanni Pascale', IRCCS, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Malzone","sequence":"additional","affiliation":[{"name":"Progetto ONCONET2.0, Linea Progettuale 14 per L'implementazione della Prevenzione e Diagnosi Precoce del Tumore alla Prostata e Testicolo, Regione Campania, Italy"},{"name":"Pathology Unit, Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d-IRCCS, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela","family":"Montanari","sequence":"additional","affiliation":[{"name":"Progetto ONCONET2.0, Linea Progettuale 14 per L'implementazione della Prevenzione e Diagnosi Precoce del Tumore alla Prostata e Testicolo, Regione Campania, Italy"},{"name":"Department of Molecular Medicine and Medical Biotechnologies, University of Naples \u201cFederico II\u201d, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Vanacore","sequence":"additional","affiliation":[{"name":"Progetto ONCONET2.0, Linea Progettuale 14 per L'implementazione della Prevenzione e Diagnosi Precoce del Tumore alla Prostata e Testicolo, Regione Campania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Quagliariello","sequence":"additional","affiliation":[{"name":"Progetto ONCONET2.0, Linea Progettuale 14 per L'implementazione della Prevenzione e Diagnosi Precoce del Tumore alla Prostata e Testicolo, Regione Campania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Piscitelli","sequence":"additional","affiliation":[{"name":"Progetto ONCONET2.0, Linea Progettuale 14 per L'implementazione della Prevenzione e Diagnosi Precoce del Tumore alla Prostata e Testicolo, Regione Campania, Italy"},{"name":"Pharmacy Unit, Istituto Nazionale Tumori, Istituto Nazionale Tumori-Fondazione G. Pascale Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Filomena","family":"Pepe","sequence":"additional","affiliation":[{"name":"Progetto ONCONET2.0, Linea Progettuale 14 per L'implementazione della Prevenzione e Diagnosi Precoce del Tumore alla Prostata e Testicolo, Regione Campania, Italy"},{"name":"Pathology Unit, Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d-IRCCS, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Berretta","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, CRO Aviano, National Cancer Institute, Aviano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"D'Aniello","sequence":"additional","affiliation":[{"name":"Progetto ONCONET2.0, Linea Progettuale 14 per L'implementazione della Prevenzione e Diagnosi Precoce del Tumore alla Prostata e Testicolo, Regione Campania, Italy"},{"name":"Division of Medical Oncology, A.O.R.N. dei COLLI \u201cOspedali Monaldi-Cotugno-CTO\u201d, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisto","family":"Perdon\u00e0","sequence":"additional","affiliation":[{"name":"Department of Uro-Gynaecological Oncology, Division of Urology, Istituto Nazionale Tumori \u2018Fondazione G. Pascale', IRCCS, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Muto","sequence":"additional","affiliation":[{"name":"Radiation Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori \u2018Fondazione Giovanni Pascale', IRCCS, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Botti","sequence":"additional","affiliation":[{"name":"Pathology Unit, Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d-IRCCS, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Ciliberto","sequence":"additional","affiliation":[{"name":"Scientific Directorate, Istituto Nazionale per lo Studio e la Cura dei Tumori \u2018Fondazione Giovanni Pascale', IRCCS, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca Maria","family":"Veneziani","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine and Medical Biotechnologies, University of Naples \u201cFederico II\u201d, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco De","family":"Falco","sequence":"additional","affiliation":[{"name":"Psicology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori \u2018Fondazione Giovanni Pascale', IRCCS, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piera","family":"Maiolino","sequence":"additional","affiliation":[{"name":"Pharmacy Unit, Istituto Nazionale Tumori, Istituto Nazionale Tumori-Fondazione G. Pascale Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Caraglia","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Biophysics and General Pathology, Second University of Naples, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Montella","sequence":"additional","affiliation":[{"name":"Epidemiology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori \u2018Fondazione Giovanni Pascale', IRCCS, Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo De","family":"Giorgi","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS, Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Facchini","sequence":"additional","affiliation":[{"name":"Progetto ONCONET2.0, Linea Progettuale 14 per L'implementazione della Prevenzione e Diagnosi Precoce del Tumore alla Prostata e Testicolo, Regione Campania, Italy"},{"name":"Division of Medical Oncology, Department of Uro-Gynaecological Oncology, Istituto Nazionale Tumori \u2018Fondazione G. Pascale', IRCCS, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,11,3]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1365-2605.2005.00622.x","article-title":"In utero exposure to persistent organic pollutants in relation to testicular cancer risk","volume":"29","author":"Carlberg","year":"2006","journal-title":"Int J Androl"},{"key":"2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1365-2605.2004.00489.x","article-title":"Concentrations of polychlorinated biphenyls in blood and the risk for testicular cancer","volume":"27","author":"Kolmert","year":"2004","journal-title":"Int J Androl"},{"key":"3","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/j.biocel.2005.06.014","article-title":"Testicular germ cell tumors: the paradigm of chemosensitive solid tumors","volume":"37","author":"de Jong","year":"2005","journal-title":"Int. J. Biochem. Cell Biol"},{"key":"4","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1111\/j.1365-2605.2011.01157.x","article-title":"Dissecting the molecular pathways of testicular germ cell tumor pathogenesis; from initiation to treatment-resistance","volume":"34","author":"Oosterhuis","year":"2011","journal-title":"Int. J. Androl"},{"key":"5","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1200\/JCO.1997.15.2.594","article-title":"International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers","volume":"15","author":"International Germ Cell Cancer Collaborative Group","year":"1997","journal-title":"J. Clin. Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1056\/NEJMra1407550","article-title":"Testicular cancer--discoveries and updates","volume":"371","author":"Einhorn","year":"2014","journal-title":"N Engl J Med"},{"key":"7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.critrevonc.2004.05.006","article-title":"Germ cell tumours of the testis","volume":"53","author":"Marangolo","year":"2005","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"8","first-page":"a001008","article-title":"TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use Cold Spring","volume":"2","author":"Hainaut","year":"2010","journal-title":"Harb Perspect Biol"},{"key":"9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1699-0463.1998.tb01323.x","article-title":"p53 tumour suppressor gene and germ cell neoplasia","volume":"106","author":"Lutzker","year":"1998","journal-title":"APMIS"},{"key":"10","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/bpa.12173","article-title":"Revisiting TP53 Mutations and Immunohistochemistry \u2014 A Comparative Study in 157","volume":"25","author":"Ichimura","year":"2015","journal-title":"Diffuse Gliomas Brain Pathology"},{"key":"11","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/modpathol.2011.85","article-title":"Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis","volume":"24","author":"Kurman","year":"2011","journal-title":"Mod Pathol"},{"key":"12","first-page":"1221","article-title":"Germ cell tumors of the testis overexpress wild-type p53","volume":"149","author":"Benhattar","year":"1996","journal-title":"Am. J. Pathol"},{"issue":"2","key":"13","first-page":"617","article-title":"Increased p53 Protein Does Not Correlate to p53 Gene Mutations in Microdissected Human Testicular Germ Cell Tumors","volume":"154","author":"Moul","journal-title":"The Journal of Urology"},{"key":"14","doi-asserted-by":"crossref","first-page":"e19198","DOI":"10.1371\/journal.pone.0019198","article-title":"p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin","volume":"6","author":"van der Kuip","year":"2011","journal-title":"PLoS ONE"},{"key":"15","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.5301\/jbm.5000149","article-title":"Germ cell tumors overexpress the candidate therapeutic target cyclin B1 independently of p53 function","volume":"30","author":"Ruffini","year":"2015","journal-title":"Int J Biol Markers"},{"key":"16","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/(SICI)1097-0215(19971114)73:4<592::AID-IJC22>3.0.CO;2-A","article-title":"Lack of correlation between cisplatin-induced apoptosis, p53 status and expression of Bcl-2 family proteins in testicular germ cell tumour cell lines","volume":"73","author":"Stoter","year":"1997","journal-title":"Int J Cancer"},{"key":"17","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1200\/JCO.2002.20.6.1551","article-title":"Role of p53 and MDM2 in treatment response of human germ cell tumors","volume":"20","author":"Looijenga","year":"2002","journal-title":"J Clin Oncol"},{"key":"18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.canlet.2016.04.016","article-title":"Wilms tumor gene 1 (WT1), TP53, RAS\/BRAF and KIT aberrations in testicular germ cell tumors","volume":"376","author":"Vernerova","year":"2016","journal-title":"Cancer Lett"},{"key":"19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-5793(97)01480-4","article-title":"Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53","volume":"420","author":"Yasuda","year":"1997","journal-title":"FEBS Lett"},{"key":"20","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1200\/JCO.2002.02.980","article-title":"p53 and MDM2 in germ cell cancer treatment response","volume":"20","author":"Berney","year":"2002","journal-title":"J Clin Oncol"},{"key":"21","first-page":"3562","article-title":"Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein","volume":"57","author":"George","year":"1997","journal-title":"Cancer Res"},{"key":"22","first-page":"1469","article-title":"The mdm-2 oncogene is translocated and overexpressed in a murine plasmacytoma cell line expressing wild-type p53","volume":"9","author":"Cole","year":"1994","journal-title":"Oncogene"},{"key":"23","unstructured":"Eid, Institoris, G\u00e9czi, Bodrogi, Bak. mdm-2 expression in human testicular germ-cell tumors and its clinical value Anticancer Res. 1999 Jul-Aug. 19(4C):3485\u201390."},{"key":"24","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.4161\/cc.9.7.11255","article-title":"p53 inactivation by MDM2 and MDMX negative feedback loops in testicular germ cell tumors","volume":"9","author":"Chen","year":"2010","journal-title":"Cell Cycle"},{"key":"25","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.1038\/cddis.2011.33","article-title":"Disruption of the MDM2-p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas\/FasL pathway","volume":"2","author":"de Jong","year":"2011","journal-title":"Cell Death Dis"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Bagrodia, Lee, Lee, Cha, Sfakianos, Iyer, Pietzak, Gao, Zabor, Ostrovnaya, Kaffenberger, Syed, Arcila, et al. Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors. J Clin Oncol. 2016 Sep 19. [Epub ahead of print].","DOI":"10.1200\/JCO.2016.68.7798"},{"key":"27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/sj.bjc.6602724","article-title":"Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours","volume":"93","author":"Dini","year":"2005","journal-title":"Br J Cancer"},{"key":"28","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1200\/JCO.2010.32.6678","article-title":"Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database","volume":"29","author":"Kollmannsberger","year":"2011","journal-title":"J Clin Oncol"},{"key":"29","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/annonc\/mdi017","article-title":"Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience","volume":"16","author":"Rosti","year":"2005","journal-title":"Ann Oncol"},{"key":"30","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMoa067749","article-title":"High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors","volume":"357","author":"Abonour","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"31","first-page":"95","article-title":"The status of high-dose chemotherapy with hematopoietic stem cell transplantation in germ cell tumor patients","volume":"87","author":"Marangolo","year":"2002","journal-title":"Haematologica"},{"key":"32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/(SICI)1097-0215(19970304)70:5<551::AID-IJC10>3.0.CO;2-G","article-title":"DNA repair capacity and cisplatin sensitivity of human testis tumor cells","volume":"70","author":"Masters","year":"1997","journal-title":"Int J Cancer"},{"key":"33","doi-asserted-by":"publisher","first-page":"e51563","DOI":"10.1371\/journal.pone.0051563","article-title":"Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to Cisplatin and poly (adp-ribose) polymerase inhibition","volume":"7","author":"Barchi","year":"2012","journal-title":"PLoS One"},{"key":"34","doi-asserted-by":"crossref","first-page":"838","DOI":"10.4161\/cc.4.6.1742","article-title":"ATM Activation in Normal Human Tissues and Testicular","volume":"4","author":"Bartek","year":"2005","journal-title":"Cancer Cell Cycle"},{"key":"35","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/ncb892","article-title":"53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer","volume":"4","author":"Halazonetis","year":"2002","journal-title":"Nat Cell Biol"},{"key":"36","doi-asserted-by":"crossref","first-page":"8545","DOI":"10.1038\/sj.onc.1207878","article-title":"Aberrations of the Chk2 tumor suppressor in advanced urinary bladder cancer","volume":"23","author":"Bartek","year":"2004","journal-title":"Oncogene"},{"key":"37","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nature03485","article-title":"Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions","volume":"434","author":"Herlyn","year":"2005","journal-title":"Nature"},{"key":"38","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nature03482","article-title":"DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis","volume":"434","author":"Bartek","year":"2005","journal-title":"Nature"},{"key":"39","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.molonc.2014.07.001","article-title":"Patterns of DNA damage response in intracranial germ cell tumors versus glioblastomas reflect cell of origin rather than brain environment: Implications for the anti-tumor barrier concept and treatment","volume":"8","author":"Bartek","year":"2014","journal-title":"Mol Oncol"},{"key":"40","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/CAD.0b013e32835a3598","article-title":"Testicular and testicular adnexa tumors in the elderly","volume":"24","author":"Facchini","year":"2013","journal-title":"Anticancer Drugs"},{"key":"41","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nature03485","article-title":"Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions","volume":"434","author":"Herlyn","year":"2005","journal-title":"Nature"},{"key":"42","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nature05327","article-title":"Oncogene induced senescence is a DNA damage response triggered by DNA hyper replication","volume":"444","author":"d'Adda di Fagagna","year":"2006","journal-title":"Nature"},{"key":"43","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1667\/RR3185.1","article-title":"Cisplatin enhances the formation of DNA single- and double-strand breaks by hydrated electrons and hydroxyl radicals","volume":"179","author":"Hunting","year":"2013","journal-title":"Radiat Res"},{"key":"44","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1101\/gad.12.24.3831","article-title":"Double-strand break repair by interchromosomal recombination: suppression of chromosomal translocations","volume":"12","author":"Jasin","year":"1998","journal-title":"Genes Dev"},{"key":"45","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/35015097","article-title":"Frequent chromosomal translocations induced by DNA double-strand breaks","volume":"405","author":"Jasin","year":"2000","journal-title":"Nature"},{"key":"46","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1093\/carcin\/bgq064","article-title":"Homologous recombination in cancer development, treatment and development of drug resistance","volume":"31","author":"Helleday","year":"2010","journal-title":"Carcinogenesis"},{"key":"47","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nm852","article-title":"Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors","volume":"9","author":"D'Andrea","year":"2003","journal-title":"Nat Med"},{"key":"48","doi-asserted-by":"crossref","first-page":"8961","DOI":"10.1158\/0008-5472.CAN-05-1187","article-title":"CpG island methylation of DNA damage response genes in advanced ovarian cancer","volume":"65","author":"Brown","year":"2005","journal-title":"Cancer Res"},{"key":"49","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/nature06633","article-title":"Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers","volume":"451","author":"Taniguchi","year":"2008","journal-title":"Nature"},{"key":"50","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/nature06548","article-title":"Resistance to therapy caused by intragenic deletion in BRCA2","volume":"451","author":"Ashworth","year":"2008","journal-title":"Nature"},{"key":"51","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1158\/0008-5472.CAN-08-0088","article-title":"Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance","volume":"68","author":"Taniguchi","year":"2008","journal-title":"Cancer Res"},{"key":"52","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ijc.11106","article-title":"The role of RAD51 in etoposide (VP16) resistance in small cell lung cancer","volume":"105","author":"Helleday","year":"2003","journal-title":"Int J Cancer"},{"key":"53","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0169-5002(03)00026-6","article-title":"DNA repair rate and etoposide (VP16) resistance of tumor cell subpopulations derived from a single human small cell lung cancer","volume":"40","author":"Spang-Thomsen","year":"2003","journal-title":"Lung Cancer"},{"key":"54","first-page":"5637","article-title":"Loss of ATM radiosensitizes multiple p53","volume":"58","author":"Leder","year":"1998","journal-title":"Null Tissues Cancer Res"},{"key":"55","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/annonc\/mdg240","article-title":"Loss of atm sensitises p53-deficient cells to topoisomerase poisons and antimetabolites","volume":"14","author":"Fink","year":"2003","journal-title":"Ann Oncol"},{"key":"56","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.radonc.2014.04.001","article-title":"Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition","volume":"111","author":"Rodemann","year":"2014","journal-title":"Radiother Oncol"},{"key":"57","first-page":"1447","article-title":"siRNA-mediated MDM2 inhibition sensitizes human lung cancer A549 cells to radiation","volume":"30","author":"Li","year":"2007","journal-title":"Int J Oncol"},{"key":"58","first-page":"3321","article-title":"Efficacy of MDM2 Inhibitor MI-219 Against Lung Cancer Cells Alone or in Combination with MDM2 Knockdown, a XIAP Inhibitor or Etoposide","volume":"30","author":"Sun","year":"2010","journal-title":"Anticancer Res"},{"key":"59","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1101\/gad.1815309","article-title":"The combined status of ATM and p53 link tumor development with therapeutic response","volume":"23","author":"Hemann","year":"2009","journal-title":"Genes Dev"},{"key":"60","doi-asserted-by":"crossref","unstructured":"Oren, Rotter. Mutant p53 gain-of-function in cancer. Cold Spring Harb Perspect Biol. 2010 Feb 2; p. a001107. https:\/\/doi.org\/10.1101\/cshperspect.a001107.","DOI":"10.1101\/cshperspect.a001107"},{"key":"61","doi-asserted-by":"publisher","first-page":"e196","DOI":"10.1038\/oncsis.2016.8","article-title":"Gain of function of mutant p53: R282W on the peak?","volume":"5","author":"Xu","year":"2016","journal-title":"Oncogenesis"},{"key":"62","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1136\/jclinpath-2012-201088","article-title":"PARP expression in germ cell tumours","volume":"66","author":"Mardiak","year":"2013","journal-title":"J Clin Pathol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T14:04:35Z","timestamp":1596722675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,3]]},"references-count":62,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2016,12,20]]}},"alternative-id":["13063","27821802"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.13063","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,3]]}}}